Suppose the effect your thesis builds on has never been independently reproduced. You could spend six months confirming it, or you could spend that time producing something new. Most advisors would recommend the second option. Most hiring committees would reward it.

That calculation is rational for the individual and corrosive for the system. Each researcher who skips verification makes a sensible career choice. Added together across a field, those choices produce a literature in which many claims rest on a single study that nobody has checked. The infrastructure of science assumes someone is doing the checking. Often, no one is.

This article examines three things: what replication actually does for scientific knowledge, why the academic reward structure discourages it, and how a researcher can choose replication work that strengthens both the literature and a CV. The goal is not to argue that everyone should become a replicator. It is to show where verification creates the most value, and how to capture some of that value for yourself.

A published finding is a claim, not a fact. Peer review assesses whether the reasoning is plausible and whether the methods, as described, appear sound. Reviewers rarely examine raw data, and they never rerun the experiment. Replication is the step where a claim is tested against reality a second time, by people who have no stake in the outcome.

It helps to distinguish two forms. A direct replication repeats the original procedure as closely as possible. A conceptual replication tests the same hypothesis with different methods or measures. Both have value, but they behave differently. A failed conceptual replication can always be attributed to the changed method, while a successful one is counted as support. A literature built only on conceptual replications can therefore accumulate evidence without ever facing a real risk of falsification.

The consequences of neglect became visible in the early 2010s. A large collaborative effort attempted to reproduce 100 published psychology studies, and fewer than half produced comparable results. Around the same time, scientists at the biotechnology company Amgen reported that they could confirm only 6 of 53 landmark cancer biology findings. These figures were not mainly evidence of fraud. They showed that a filtering step the system depended on had been quietly skipped for decades.

The cost of skipping that step falls on everything built afterwards. Follow-up grants, doctoral projects, clinical trials and entire subfields can rest on foundations that were never inspected. Errors in science are supposed to cancel out over time. Without replication, they compound instead. Vannevar Bush described science as an endless frontier, but a frontier only holds if the ground behind it is solid.

Takeaway

A finding published once has been proposed, not established. Replication is the moment a claim stops belonging to its author and starts belonging to the field.

The currency of academic science is novelty. High-impact journals select for surprising results. Grant panels score proposals on innovation. Tenure committees count first-author papers in prominent venues. A replication is, by definition, not new, so it is poorly positioned on every metric that shapes a career.

The outcomes are also asymmetric. A successful replication tends to be received with indifference: we already knew that. A failed replication is contested. Original authors may dispute the methods, and reviewers often demand more evidence from the replication than the original study ever had to provide. In small fields there is a social cost as well. Challenging a senior researcher's signature finding can affect future reviews, collaborations and letters of recommendation.

At the level of the whole system, the effects add up. Publication bias already favours positive results. Combine it with a scarcity of replication and the literature comes to over-represent inflated effects. Small studies that happen to find large effects get published, while the ones that don't stay in file drawers. This pattern is known as the winner's curse. Meta-analyses that aggregate these studies inherit the bias, so a field's confidence can grow faster than its evidence.

None of this is inevitable. Registered Reports, in which journals accept a study in principle before data are collected, remove the penalty for null results. Some journals now run dedicated replication tracks. A few national funders have launched replication grant schemes, and some hiring committees have begun to credit data sharing and methodological rigour. These changes remain marginal. Still, they demonstrate that the incentive structure is a design choice rather than a law of nature.

Takeaway

Researchers respond rationally to the incentives they face. When a system keeps producing unreliable knowledge, the more useful question is not who is careless, but what the rewards are selecting for.

Not all replications are equally valuable. The strongest targets share recognisable features: they are heavily cited, they relied on small original samples, they reported unusually large effects, and they carry weight for other research or for policy and clinical decisions. One diagnostic question helps: if this finding were false, what would collapse? The larger the answer, the more a replication contributes.

The most career-compatible design is often replicate-and-extend. A project begins by reproducing a key prior effect in your own lab, then adds a new manipulation, moderator or population. The replication works as a validity check for your own paradigm, gives students hands-on training, and anchors a publishable novel contribution. Many graduate projects already do this informally. Reporting the replication explicitly turns hidden labour into a visible result.

Venue and structure matter too. Registered Reports remove outcome risk, because publication is guaranteed if the approved protocol is followed. Multi-site collaborative replications produce large samples, high-citation papers and author lists that connect early-career researchers with established labs across institutions. The skills involved, such as power analysis, preregistration and protocol standardisation, carry over to every project that follows.

Conduct shapes how the work is received. Contact the original authors early, request their materials, and invite comments on your protocol before collecting data. Frame the study as a test of a claim, not a verdict on a person. Report results precisely. Confidence intervals and equivalence tests say far more than a bare statement that a finding "failed to replicate." Done this way, replication builds a reputation for rigour, and that reputation compounds over a career.

Takeaway

The choice is not between replication and original research, but about where verification is the most valuable contribution you can make. Choose claims that carry weight, and your work will carry weight too.

Replication is how a scientific claim earns its standing. Without it, peer-reviewed literature becomes a collection of plausible proposals, some sound and some not, with no reliable way to tell them apart.

The scarcity of replication is not a moral failing of individual scientists. It follows predictably from a reward structure built around novelty. That structure is slowly being redesigned through Registered Reports, replication funding and changing hiring criteria, but the pace of change depends partly on researchers who demonstrate that verification can be valuable work.

For the individual, the practical lesson is selectivity. Replicate findings that bear weight, build replication into your original projects, and use formats that protect you from outcome risk. Verification, chosen well, is part of the work of discovery.